Cargando…
The PATCH trial: efficacy and safety of 5% lidocaine-medicated plaster for the treatment of patients with trigeminal neuralgia: a study protocol for a multicentric, double-blind, enriched enrolment randomised withdrawal, vehicle-controlled study
INTRODUCTION: Trigeminal neuralgia (TN) is characterised by a sudden, severe, electric shock like paroxysmal pain, which is almost always associated with triggers. Carbamazepine is the first-line medical management of TN. However, side effects are common. Currently, there is no ideal treatment for T...
Autores principales: | Zhao, Chunmei, Shrestha, Niti, Liu, Hongbing, Shen, Ying, Meng, Lan, Fan, Bifa, Luo, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330571/ https://www.ncbi.nlm.nih.gov/pubmed/34341037 http://dx.doi.org/10.1136/bmjopen-2020-045493 |
Ejemplares similares
-
Health economic evidence of 5% lidocaine medicated plaster in post-herpetic neuralgia
por: Liedgens, Hiltrud, et al.
Publicado: (2013) -
Effect of duloxetine premedication for postherpetic neuralgia within 72 h of herpes zoster reactivation [PROCESS]: a study protocol for a randomized controlled trial
por: Chen, Zheng, et al.
Publicado: (2020) -
5% Lidocaine Medicated Plaster for the Treatment of Postherpetic Neuralgia: A Review of the Clinical Safety and Tolerability
por: Navez, Marie Louise, et al.
Publicado: (2015) -
Evaluation of the Population Pharmacokinetic Properties of Lidocaine and its Metabolites After Long-Term Multiple Applications of a Lidocaine Plaster in Post-Herpetic Neuralgia Patients
por: Bursi, Roberta, et al.
Publicado: (2017) -
Influence of anatomic location of lidocaine patch 5% on effectiveness and tolerability for postherpetic neuralgia
por: Nalamachu, Srinivas, et al.
Publicado: (2013)